PLS

UPDATE
www.physlab.com MAY 2015

PREPARING FOR ICD­10

On October 1, 2015, the healthcare industry will be moving over to ICD­10 (International Classification of Diseases 10 th
Revision) system. Complete and accurate codes will be necessary to submit claims. It is imperative that the appropriate ICD­
10 diagnosis code is noted on all requisitions. Failure to utilize the new coding system will result in unnecessary calls to your
office as Physicians Laboratory will be unable to process the insurance claim without this information.

Resources for ICD­10 Transition:

Medicare has developed a site to assist Physician practices with this transition. The web address is http://www.roadto10.org.
This website will help your office build a customized action plan for implementation. Additionally, it provides specific
references based on your type of specialty (Family Practice, Pediatrics, OB/GYN, etc). There are videos, webcasts and
template library’s available as well.

Additional ICD­10 websites:

http://www.cms.gov/Medicare/coding/ICD10
http://www.cms.gov/medicare/coding/ICD10/providerresources.html
https://www.aapc.com/icd­10/icd­10­news.aspx

PAIN MANAGEMENT TESTING

Several physicians have expressed interest in an affordable comprehensive pain management screen. ARUP now offers two
panels that are performed using Time­of­Flight Mass Spectrometry and Enzyme Immunoassays that encompass all pertinent
drug classes needed to monitor patients that are in pain management programs.
Test #8850 Pain Management Drug Panel by High Resolution Time of Flight Mass Spectrometry and Enzyme
Immunoassay, Urine.
Specimen Type: Refrigerated Random Urine CPT: 80304, 80301, 80302x3 / (Medicare G0431)
Drug Classes Included:
� Barbiturates
� Benzodiazepine­like:
o Alprazolam, Clonazepam, Diazepam, Lorazepam, Midazolam, Nordiazepam,
Oxazepam, Temazepam, Zolpidem.
� Cannabinoids (11­nor­9­carboxy­THC)
� Ethyl Glucuronide
� Muscle Relaxant(s):
o Carisoprodol, Meprobamate
� Opiates/Opiods:
o Buprenorphine, Codeine, Fentanyl, Heroin, Hydrocodone, Hydromorphone, Meperidine, Methadone,
Morphine, Oxycodone, Oxymorphone, Propoxyphene, Tapentadol, Tramadol.
� Phencyclidine (PCP)
� Stimulants:
o Amphetamine, Cocaine, Methamphetamine, Methylphenidate, MDMA (Ecstasy), MDEA (Eve), MDA,
Phentermine.
Test #8851 Pain Management Drug Panel with interpretation by High Resolution Time of Flight Mass Spectrometry and
Enzyme Immunoassay, Urine.
** If you order test #8851, which includes an interpretation, you must include a list of the patient’s
prescribed medications
Specimen Type: Refrigerated Random Urine CPT: 80304, 80301, 80302x3 / (Medicare G0431)
Drug Classes Included:
� Barbiturates
� Benzodiazepine­like:
o Alprazolam, Clonazepam, Diazepam, Lorazepam, Midazolam, Nordiazepam,
Oxazepam, Temazepam, Zolpidem.
� Cannabinoids (11­nor­9­carboxy­THC)
� Ethyl Glucuronide
� Muscle Relaxant(s):
o Carisoprodol, Meprobamate
� Opiates/Opiods:
o Buprenorphine, Codeine, Fentanyl, Heroin, Hydrocodone, Hydromorphone, Meperidine, Methadone,
Morphine, Oxycodone, Oxymorphone, Propoxyphene, Tapentadol, Tramadol.
� Phencyclidine (PCP)
� Stimulants:
o Amphetamine, Cocaine, Methamphetamine, Methylphenidate, MDMA (Ecstasy), MDEA (Eve), MDA,
Phentermine.
If you would like more information regarding these panels, please contact Dr. Greg Post, Clinical Director at 402­326­0617.

DISCONTINUED TESTS ~ EFFECTIVE IMMEDIATELY

#267 pH, Venous

#405 Leukocyte Alkaline Phosphatase (LAP)

The LAP test historically has been used to screen for chronic myelogenous leukemia (CML) and polycythemia vera
(PV). The assay has poor sensitivity with other nonmalignant conditions causing false positive results. Newer, more
specific assays have been developed and have replaced this obsolete test.
When working up a possible CML diagnosis, the recommendations are to test for:
� Qualitative RT­PCR for BCR/ABL
� FISH for BCR/ABL
� Karyotyping
To help establish the diagnosis of PV, the recommended tests are:
� Erythropoietin
� JAK2 mutation analysis
If you have any questions concerning this testing, please direct them to Gregory Post. Ph.D., our Director of Clinical
Services at 402­326­0617.

SPECIMEN COLLECTION / APTIMA GEN-PROBE

Test #1982 Chlamydia/GC PCR, Swab Test #1989 Chlamydia PCR, Swab
Test #2000 Chlamydia/GC/Trichomonas Panel by PCR Test #1990 N. Gonorrhoeae PCR, Swab
Please submit only the blue swab for testing. The white swab should be used only for cleaning mucous from the cervix before
sampling with the blue swab. For males, this swab is not used and can be discarded. If the white swab is submitted, the tests
will not be performed and recollection will be necessary.
SPECIMEN REQUIREMENT UPDATE ~ TROPONIN I
Test #1565 Troponin I
Specimen: 0.5mL Plasma Heparinized
Stability: Ambient 2 hours. Refrigerated 24 hours.
Processing: Centrifuge green top tube within 2 hours of collection. Transfer plasma to a transport tube.
**EFFECTIVE APRIL 15, 2015 – SERUM IS NO LONGER ACCEPTABLE**

CPT CODE UPDATES ~ EFFECTIVE MAY 1, 2015

Test #1409 Coenzyme Q10, Total Previous CPT: 82491 New CPT: 83789
Test #7550 TSH Receptor Antibody Previous CPT: 83520 New CPT: 83516
Test #1754 Pancreatic Elastase, Fecal Previous CPT: 83520 New CPT: 82656
Test #702 Alcohol, Serum Previous CPT: 82055 New CPT: 80301 / Medicare (G0431)
Test #7658 HPV Type Detect 3.0 Previous CPT: 87798/87624 New CPT: 87624

PRICING UPDATES ~ EFFECTIVE MAY 1, 2015

Test # Test Name Performing Lab
7650 Hepatitis C Viral Load by Real­Time PCR PAML
7258 HIV­1 Ultrasensative RNA PCR PAML
9323 Aspergillus Galactomannan Antigen by EIA ARUP
7649 Cystic Fibrosis 32 Mutations ARUP
637 Fecal Fat, Qualitative ARUP

MEDICAID – DRUG TESTING & SEMEN ANALYSIS

Nebraska Medicaid will not cover toxicology or semen analysis testing. If you want to order this testing on a Medicaid
patient, you must inform them that the test will not be covered under their insurance and have them complete an ABN
(Advanced Beneficiary Notice) prior to collection of the sample.

PHYSICIANS LABORATORY’S WEBSITE ~ UPDATE TO TEST DIRECTORY

WWW.PHYSLAB.COM
Physicians Laboratory is updating test requirements on our website to include patient preparation instructions, a preferred
specimen type and detailed specimen processing information. Our goal is to make our website more user­friendly so that
specimen collection requirements are clear and concise. Other functionality that is available at www.physlab.com:
� CAP/CLIA Certificates
� Online Results
� Required Forms (ABN/Preauthorization/etc.)
� Supply Orders
� Past Technical Bulletins and Billing Updates

TECHNICAL BULLETINS ~ EMAIL DISTRIBUTION

Technical bulletins and billing updates are distributed via email by request. If you would like to receive notices by email,
please contact Kacey Moreland at kmoreland@physlab.com or (800)642­1117 in order to have your name added to the
distribution list.
PHYSICIANS LABORATORY CONTACTS:

Client Services / Clinical Processing:

Patsi Tobey (Lincoln Lab Supervisor):

ptobey@physlab.com
(402)488­7710

Crystal Waymire (Omaha Lab Supervisor) Amy Sanders (Omaha Lab Supervisor)
cwaymire@physlab.com asanders@physlab.com
(402)731­4145 (402)731­4145

Information Technology Department

(800)642­1117 or (402)731­4145

Brian Kelly Bob Frenzel

IT Specialist/Client Support Interface Engineer
bkelly@physlab.com bfrenzel@physlab.com

Sean Campbell Rick Noda

IT Specialist/Client Support LIS Administrator
scampbell@physlab.com rnoda@physlab.com

Jeff Irwin
IT Specialist/Client Support
jirwin@physlab.com

Consultants & Marketing Personnel

Gregory Post, PhD Patti Seidel

Director of Clinical Services Consultant
gpost@physlab.com pseidel@physlab.com
(402)326­0617 (402)690­9802

Bev Ruch Angie Wilcoxson

Marketing Representative Marketing Representative
bruch@physlab.com awilcoxson@physlab.com
(402)660­6760 (402)660­4858

Kacey Moreland
Director of Marketing
kmoreland@physlab.com
(402)677­8872